4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-012968
EVP, Chief Medical Officer sold 1,186 shares at $14.83 ($17,590)
From the SEC's structured data for this filing
Trades in this filing
Shah Jatin · EVP, Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-18 | Sale : show line 1 in the form | −1,186 | $14.83 | $17,590 | 51,791 | D |
| Open-market sales · 1,186 sh · avg $14.83 · $17,590 | ||||||
Loading xslF345X03/doc4.xml…